Skip to main content
Intermediate Technical IVT

fecal immunochemical test

Colorectal cancer screening test that detects human hemoglobin in stool samples using antibody-based technology.

Full Definition

The fecal immunochemical test is a noninvasive colorectal cancer screening method that uses antibodies specific to human hemoglobin to detect blood in stool samples. FIT offers advantages over guaiac-based tests including no dietary restrictions, single-sample collection, and improved specificity for lower gastrointestinal bleeding. The test is typically performed annually and serves as either a primary screening modality or as part of organized screening programs. Positive FIT results require follow-up with diagnostic colonoscopy to identify the source of bleeding and evaluate for colorectal neoplasia.

Usage

Usage note: Distinguish from guaiac-based FOBT; emphasize annual testing requirement.

In Context

  • "Annual fecal immunochemical testing is recommended for average-risk patients declining colonoscopy." — Screening guideline
  • "The laboratory reported a positive FIT result requiring urgent colonoscopy referral." — Laboratory report

Also known as

FIT immunochemical fecal occult blood test iFOBT

Don't confuse with

guaiac-based FOBT multitarget stool DNA test

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON